UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

Antimicrobial Agents and Chemotherapy, 2012-06, Vol.56 (6), p.3448-3452

2012

Volltextzugriff (PDF)

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin

Antimicrobial agents and chemotherapy, 2015-10, Vol.59 (10), p.6437-6443

2015

Volltextzugriff (PDF)

National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004

Antimicrobial Agents and Chemotherapy, 2007-05, Vol.51 (5), p.1649-1655

2007

Volltextzugriff (PDF)

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936)

Antimicrobial Agents and Chemotherapy, 1999-04, Vol.43 (4), p.738-744

1999

Volltextzugriff (PDF)

In Vitro Activities of Tigecycline against the Bacteroides fragilis Group

Antimicrobial Agents and Chemotherapy, 2004-03, Vol.48 (3), p.1034-1036

2004

Volltextzugriff (PDF)

National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends for 1997–2000

Clinical infectious diseases, 2002-09, Vol.35 (Supplement-1), p.S126-S134

2002

Volltextzugriff (PDF)

Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens

Antimicrobial Agents and Chemotherapy, 2000-12, Vol.44 (12), p.3447-3450

2000

Volltextzugriff (PDF)

Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009

Anaerobe, 2017-02, Vol.43, p.21-26

2017

Volltextzugriff (PDF)

In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

Antimicrobial Agents and Chemotherapy, 2002-10, Vol.46 (10), p.3276-3279

2002

Volltextzugriff (PDF)

Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996

Antimicrobial agents and chemotherapy, 1999-10, Vol.43 (10), p.2417-2422

1999

Volltextzugriff (PDF)

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009

Anaerobe, 2011-08, Vol.17 (4), p.147-151

2011

Volltextzugriff (PDF)

Antimicrobial substance from a human Lactobacillus strain

Antimicrobial Agents and Chemotherapy, 1987-08, Vol.31 (8), p.1231-1233

1987

Volltextzugriff (PDF)

Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves

Journal of chemotherapy (Florence), 2005-12, Vol.17 (6), p.614

2005

Volltextzugriff (PDF)

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines

Antimicrobial Agents and Chemotherapy, 1993-11, Vol.37 (11), p.2270-2277

1993

Volltextzugriff (PDF)

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation

Antimicrobial Agents and Chemotherapy, 1988-05, Vol.32 (5), p.717-722

1988

Volltextzugriff (PDF)

TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases

Antimicrobial Agents and Chemotherapy, 1996-01, Vol.40 (1), p.260-262

1996

Volltextzugriff (PDF)

Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of Bacteroides fragilis group : Effect of the medium on test results

Antimicrobial agents and chemotherapy, 2000-06, Vol.44 (6), p.1710-1712

2000

Volltextzugriff (PDF)

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

Antimicrobial Agents and Chemotherapy, 1989-11, Vol.33 (11), p.1964-1969

1989

Volltextzugriff (PDF)

In Vivo Activities of Peptidic Prodrugs of Novel Aminomethyl Tetrahydrofuranyl-1β-Methylcarbapenems

Antimicrobial Agents and Chemotherapy, 1999-03, Vol.43 (3), p.460-464

1999

Volltextzugriff (PDF)

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I

Antimicrobial Agents and Chemotherapy, 1991-01, Vol.35 (1), p.203-207

1991

Volltextzugriff (PDF)

Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007)

Clinical infectious diseases, 2010-01, Vol.50 (Supplement-1), p.S26-S33

2010

Volltextzugriff (PDF)

In Vitro Activities of Aminomethyl-Substituted Analogs of Novel Tetrahydrofuranyl Carbapenems

Antimicrobial Agents and Chemotherapy, 1999-03, Vol.43 (3), p.454-459

1999

Volltextzugriff (PDF)

Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines

Journal of antimicrobial chemotherapy, 1995-07, Vol.36 (1), p.225-230

1995

Volltextzugriff (PDF)

In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

Antimicrobial agents and chemotherapy, 2003-02, Vol.47 (2), p.831-831

2003

Volltextzugriff (PDF)

Emergence of fluoroquinolone resistance among Bacteroides species

Journal of antimicrobial chemotherapy, 2003-08, Vol.52 (2), p.208-213

2003

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Englisch
(147)

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(98)
Biological And Medical Sciences
(59)
Humans
(59)
Medical Sciences
(54)
Microbial Sensitivity Tests
(49)
Microbiology
(47)
Pharmacology. Drug Treatments
(45)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(43)
Pharmacology & Pharmacy
(43)
Antibacterial Agents
(39)
Anti-Bacterial Agents - Pharmacology
(38)
Female
(28)
Infectious Diseases
(24)
Bacteroides Fragilis - Drug Effects
(23)
Male
(22)
Bacteroides Fragilis
(21)
Drug Resistance, Microbial
(21)
Research Article
(21)
Anti-Bacterial Agents
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens

U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin

National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936)

In Vitro Activities of Tigecycline against the Bacteroides fragilis Group

National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends for 1997–2000

Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens

Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010–2012 with comparison to 2008–2009

In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996

Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006–2009

Antimicrobial substance from a human Lactobacillus strain

Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation

TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases

Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of Bacteroides fragilis group : Effect of the medium on test results

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

In Vivo Activities of Peptidic Prodrugs of Novel Aminomethyl Tetrahydrofuranyl-1β-Methylcarbapenems

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I

Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007)

In Vitro Activities of Aminomethyl-Substituted Analogs of Novel Tetrahydrofuranyl Carbapenems

Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines

In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms

Emergence of fluoroquinolone resistance among Bacteroides species

Suchergebnisse filtern